Search research articles
Contact Us
Filters
Showing results (251-260 of 265) with videos related to
Page
of 27
Sort By:
NPJ Breast Cancer
|
July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study
Simone Scagnoli, Simona Pisegna, Angela Toss, et al.
Journal of Translational Medicine
|
October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
Patrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.
JNCI Cancer Spectrum
|
October 15, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
Alessandra Fabi, Antonio Franco, Laura Cortesi, et al.
Plos One
|
September 5, 2015
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
Stefania Gori, Alessandro Inno, Elena Fiorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials
Benedetta Conte, Luca Boni, Giancarlo Bisagni, et al.
Critical Reviews in Oncology/Hematology
|
June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report
Federica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
Oncotarget
|
January 8, 2019
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Journal of Cancer Policy
|
January 14, 2026
Defining the Role and Competencies of the Medical Oncologist in Diagnostic and Therapeutic Care Pathways: Consensus Recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Francesca Rossi, Valentina Tarantino, et al.
La Radiologia Medica
|
July 7, 2026
Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM)
Vincenza Granata, Alessandro Serafini, Roberta Fusco, et al.
Oncotarget
|
October 24, 2018
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 265) with videos related to
Sort By:
Page
of 27
NPJ Breast Cancer
|
July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study
Simone Scagnoli, Simona Pisegna, Angela Toss, et al.
Journal of Translational Medicine
|
October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
Patrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.
JNCI Cancer Spectrum
|
October 15, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
Alessandra Fabi, Antonio Franco, Laura Cortesi, et al.
Plos One
|
September 5, 2015
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer
Stefania Gori, Alessandro Inno, Elena Fiorio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials
Benedetta Conte, Luca Boni, Giancarlo Bisagni, et al.
Critical Reviews in Oncology/Hematology
|
June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report
Federica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
Oncotarget
|
January 8, 2019
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Journal of Cancer Policy
|
January 14, 2026
Defining the Role and Competencies of the Medical Oncologist in Diagnostic and Therapeutic Care Pathways: Consensus Recommendations from the Italian Association of Medical Oncology (AIOM)
Rossana Berardi, Francesca Rossi, Valentina Tarantino, et al.
La Radiologia Medica
|
July 7, 2026
Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM)
Vincenza Granata, Alessandro Serafini, Roberta Fusco, et al.
Oncotarget
|
October 24, 2018
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Page
of 27